Inhibition of mTOR by the addition of rapamycin, upregulation of TSC2 or blockade of STAT3 in monocytes/macrophages has been shown to promote the release of M1 cytokines and inhibit tumor growth, which was confirmed by reduced tumor angiogenesis. This evidence concerns the gene TSC2 and neoplasm.